Adaptive Industry Symposium

Measurable Residual Disease (MRD) in Multiple Myeloma: A Real-World Experience Perspective

Saturday, May 8, 2021 – 20:00-21:00 CEST

Joaquin Martinez-Lopez
Madrid, Spain

Karthik Ramasamy
Oxford, UK

Rafael Fonseca
Scottsdale, AZ – USA

AGENDA:

20:00-20:15 Monitoring Measurable Residual Disease (MRD) for the Management of Multiple Myeloma Patients (MM): Real-World Evidence
Joaquin Martinez-Lopez, Madrid, Spain
20:15-20:30 Monitoring MRD in Clinical Practice in a Dynamic Multiple Myeloma (MM) Treatment Landscape – Introducing the Delphi Initiative
Karthik Ramasamy, Oxford, UK
20:30-20:45 Managing Multiple Myeloma (MM) in Real-World Practice: Clinical Actionability of MRD
Rafael Fonseca, Scottsdale, AZ – USA
20:45-21:00 Panel Discussion / Q&A
Symposium Survey